Medi Assist Healthcare Services cash flow

Latest FY26

Cash from operations: ₹118cr−14.5% on FY25
Capital spending: ₹55.9cr+22.1% on FY25
Free cash flow: ₹62.1cr−32.7% on FY25
Cash from financing: ₹11.9cr−89.4% on FY25

₹ crore except per share

Tap a line for its trend	Last 12Mto Sep 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024

Adjustments to reconcile profit — non-cash items
	—	77.1	55.8	43.1
	—	0.0	0.0	2.7
	—	21.4	10.3	3.2
	—	0.0	0.0	−10.8
	—	−6.7	−9.6	−2.2
	—	3.2	1.6	3.8
	—	2.3	0.3	0.1
	—	4.7	6.8	−6.8
	—	0.0	0.2	21.0
Changes in working capital
	—	−29.6	−47.7	−41.1
	—	26.1	0.0	0.0
	—	12.7	0.0	0.0
	—	−10.8	−12.6	−1.9
	—	8.3	−0.9	0.0
	—	−11.5	−10.8	8.8
	—	−23.3	0.0	0.0
	—	−1.2	0.0	0.0
	—	−7.8	41.4	−6.3
	—	0.0	0.7	0.0
	—	5.1	1.0	−4.3
	—	4.8	1.5	0.0
Cash from operating activities
	101	80.4	112	84.4
	—	74.8	37.8	9.2
	—	155	150	93.6
	—	−8.2	−12.1	0.0
	—	−2.5	−0.9	0.0
	—	26.5	−1.5	27.2
	—	118	138	66.4
Cash from investing activities
	—	55.9	45.8	18.4
	—	0.0	0.0	0.6
	—	0.0	3.9	0.0
	—	402	0.0	109
	—	4.6	13.6	10.1
	—	294	−190	62.1
	—	−160	−218	−54.9
Cash from financing activities
	—	196	0.0	15.3
	—	8.8	8.1	0.0
	—	0.0	150	−0.1
	—	155	0.0	0.0
	—	23.3	15.3	16.2
	—	14.6	2.7	0.7
	—	0.0	28.1	13.0
	—	11.9	112	−14.8
	—	−29.7	31.9	−3.2
	—	1.3	0.2	0.2
	—	−28.4	32.1	−3.0
	—	—	—	50.9
Reference items
	190	175	154	133
	19.8%	19.3%	21.3%	21.0%
	62.1	62.1	92.3	48.0
	—	−103	240	—
	₹8.32	₹8.32	₹12.37	₹6.43
	35.79×	—	—	—
	—	1.32×	1.51×	0.96×
	—	26.5	−1.5	27.2
	—	14.6	2.7	0.7

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

MEDIASSIST₹297.90

Medi Assist Healthcare Services Limited

· Banking & Finance

₹ CroreMcap ₹2,223 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/09/2026
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation	43.1	55.8	77.1	—
+ Impairment Loss / (Reversal)	2.7	0.0	0.0	—
+ Finance Costs	3.2	10.3	21.4	—
+ Interest Income	-10.8	0.0	0.0	—
+ Fair Value (Gains) / Losses	-2.2	-9.6	-6.7	—
+ Share-based Payments	3.8	1.6	3.2	—
+ Unrealised FX (Gain) / Loss	0.1	0.3	2.3	—
+ Other Non-cash Items	-6.8	6.8	4.7	—
+ Other Reconciling Items	21.0	0.2	0.0	—
Changes in Working Capital
+ Trade Receivables — Current	-41.1	-47.7	-29.6	—
+ Other Financial Assets — Current	0.0	0.0	26.1	—
+ Other Financial Assets — Non-current	0.0	0.0	12.7	—
+ Other Current Assets	-1.9	-12.6	-10.8	—
+ Other Non-current Assets	0.0	-0.9	8.3	—
+ Trade Payables — Current	8.8	-10.8	-11.5	—
+ Other Financial Liabilities — Current	0.0	0.0	-23.3	—
+ Other Financial Liabilities — Non-current	0.0	0.0	-1.2	—
+ Other Current Liabilities	-6.3	41.4	-7.8	—
+ Other Non-current Liabilities	0.0	0.7	0.0	—
+ Provisions — Current	-4.3	1.0	5.1	—
+ Provisions — Non-current	0.0	1.5	4.8	—
Cash from Operating Activities
Profit Before Tax (per I/S)	84.4	111.8	80.4	101.0
+ Total Adjustments (incl. Working Capital)	9.2	37.8	74.8	—
Cash from Operations (pre-tax)	93.6	149.6	155.1	—
+ Interest Received — Operating	0.0	-12.1	-8.2	—
+ Other Inflows / (Outflows) — Operating	0.0	-0.9	-2.5	—
+ Income Taxes Paid	27.2	-1.5	26.5	—
Cash from Operating Activities	66.4	138.1	118.0	—
Cash from Investing Activities
+ Acq of Fixed Assets (Capex)	18.4	45.8	55.9	—
+ Disp of Fixed Assets	0.6	0.0	0.0	—
+ Sale of Investments (Equity / Debt)	0.0	3.9	0.0	—
+ Acq of Subsidiaries / Businesses (net)	109.3	0.0	401.9	—
+ Interest Received — Investing	10.1	13.6	4.6	—
+ Other Inflows / (Outflows) — Investing	62.1	-189.9	293.5	—
Cash from Investing Activities	-54.9	-218.2	-159.6	—
Cash from Financing Activities
+ Proceeds from Issue of Shares	15.3	0.0	196.2	—
+ Proceeds from Exercise of Stock Options	0.0	8.1	8.8	—
+ Proceeds from Borrowings	-0.1	150.1	0.0	—
+ Repayment of Borrowings	0.0	0.0	155.1	—
+ Payment of Lease Liabilities	16.2	15.3	23.3	—
+ Interest Paid	0.7	2.7	14.6	—
+ Dividends Paid	13.0	28.1	0.0	—
Cash from Financing Activities	-14.8	112.1	11.9	—
Net Changes in Cash (pre-FX)	-3.2	31.9	-29.7	—
+ Effect of FX Rate Changes on Cash	0.2	0.2	1.3	—
Net Changes in Cash	-3.0	32.1	-28.4	—
Closing Cash	50.9	—	—	—
Reference Items
EBITDA	133.3	154.1	174.6	190.1
EBITDA Margin %	21.00	21.31	19.30	19.81
Free Cash Flow (CFO − Capex)	48.0	92.3	62.1	62.1
Free Cash Flow to Equity	—	239.7	-102.6	—
Free Cash Flow per Basic Share	6.43	12.37	8.32	8.32
Price to Free Cash Flow	—	—	—	35.79
Cash Flow to Net Income	0.96	1.51	1.32	—
Cash Paid for Taxes	27.2	-1.5	26.5	—
Cash Paid for Interest	0.7	2.7	14.6	—

As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.